Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/20616
Title: | Neoadjuvant as Future for Drug Development in Breast Cancer-Letter | Authors: | BUYSE, Marc BURZYKOWSKI, Tomasz Saad, Everardo D. |
Issue Date: | 2016 | Publisher: | AMER ASSOC CANCER RESEARCH | Source: | CLINICAL CANCER RESEARCH, 22 (1), p. 268-268 | Notes: | [Buyse, Marc] Int Inst Drug Dev, San Francisco, CA USA. [Buyse, Marc; Burzykowski, Tomasz] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat I BioSt, Hasselt, Belgium. [Burzykowski, Tomasz; Saad, Everardo D.] Int Inst Drug Dev, Louvain La Neuve, Belgium. [Saad, Everardo D.] Dendrix Res, Sao Paulo, Brazil. | Document URI: | http://hdl.handle.net/1942/20616 | ISSN: | 1078-0432 | e-ISSN: | 1557-3265 | DOI: | 10.1158/1078-0432.CCR-15-1047 | ISI #: | 000367550300030 | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2017 |
Appears in Collections: | Research publications |
Show full item record
SCOPUSTM
Citations
4
checked on Sep 2, 2020
WEB OF SCIENCETM
Citations
4
checked on Sep 12, 2024
Page view(s)
64
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.